Brief: Verona Pharma PLC Announces Pricing Of Upsized Underwritten Public Offering
11/08/2022 01:26
Aug 10 (Reuters) - Verona Pharma PLC I9SAy.F :
* VERONA PHARMA PLC ANNOUNCES PRICING OF
UPSIZED UNDERWRITTEN
PUBLIC OFFERING
* VERONA PHARMA - PRICING OF UPSIZED PUBLIC OFFERING OF 12.4
MLN
AMERICAN DEPOSITARY SHARES, NOMINAL VALUE £0.05 PER SHARE, AT
PRICE OF $10.50 PER ADS
Source text for Eikon: ID:nGNX7xMwy3
Further company coverage: I9SAy.F
((Reuters.Brief@thomsonreuters.com;))
Recent news on Verona Pharma
See all newsBrief: Acquisition Of Verona By Msd Approved By The High Court Of Justice Of England And Wales
Brief: Shareholders Of Verona Pharma Approve Proposed Acquisition By Merck
US corporate debt market returns in force after market holiday
Merck to cut jobs and costs as demand for Gardasil in China remains weak (updated)
Merck to cut jobs and costs as demand for Gardasil in China remains weak